Provider review
Options Medical Weight Loss review
Medication is inside every figure, and it disclaims affiliation with the brand makers.
The step from semaglutide to tirzepatide here is a full doubling, wider than most.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Options Medical Weight Loss
$199/mo semaglutide and $399/mo tirzepatide, medication included
- Vs median
- $30/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The medication is inside the number on every line and each card says so, which puts this ahead of the membership-plus-drug structures common in this category. It also carries a disclaimer worth noting: an explicit statement that the company is not affiliated with the two manufacturers of the branded products, printed under the products rather than buried in the terms. Compounded sellers borrow the reputation of those brands constantly, and most leave the distinction for you to work out. Stating it is the better behavior and it is not common. The pricing has one feature to flag before starting. The gap between the two molecules here is a full doubling, where a third to a half is the usual spread, so if you expect to move from semaglutide to tirzepatide you should price that step now rather than discover it later. All three figures are floors, and no milligram is published against any of them.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the medication included in the advertised figure
- You value a provider stating plainly what it is not affiliated with
- You may not qualify for a GLP-1 and want a non-GLP-1 option priced alongside
Look elsewhere if
- You expect to move to tirzepatide — the step here is a doubling
- You want a published price at a working dose rather than a floor
- You want a dose behind the number
What it actually costs
Price as published
Three lines, each with the medication included stated on the card: semaglutide "Starting at $199/mo. Medication Included", tirzepatide "Starting at $399/mo. Medication Included", and phentermine tablets "Starting at $149/mo" · ★ THE TIRZEPATIDE PREMIUM IS UNUSUALLY LARGE — twice the semaglutide figure, where most sellers here run a gap of a third to a half · ★ and an explicit disclaimer sits under the products: "Options Medical is not affiliated with Novo Nordisk or Eli Lilly", which is a statement most compounded sellers leave to a reader to work out · all three are floors — "Starting at" — with no rung above published · no milligram is published
- Vs median
- $30/mo above the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. Medication included in every figure and said so on every card, plus an explicit disclaimer of affiliation with the brand manufacturers — both good behavior. For a reader planning to move molecules the step matters more than the entry price: tirzepatide is DOUBLE semaglutide here, wider than the usual spread. No low-dose product, no dose published, and all three figures are floors.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Medication is included in every advertised figure, stated on each card.
- Explicitly disclaims affiliation with the brand-name manufacturers.
- A non-GLP-1 option is priced alongside, for readers who do not qualify or do not want one.
Pharmacy, labs and oversight
Options Medical Weight Loss does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Options Medical Weight Loss publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The medication is inside the number on every line and the card says so, which puts this ahead of the membership-plus-drug structures elsewhere on the page. It also carries a disclaimer that deserves noting: an explicit statement that the company is not affiliated with the two manufacturers of the branded products, printed under the products rather than buried in terms. Compounded sellers borrow the reputation of the brands constantly and most leave the distinction to the reader; stating it is the better behavior. The pricing itself has one feature worth flagging. The gap between the two molecules here is a full doubling, which is wider than the third-to-half spread common in this category, so anyone expecting to move from semaglutide to tirzepatide should price that step before starting rather than after. All three figures are floors, and no milligram is published against any of them.
The honest cons
The tirzepatide figure is double the semaglutide one, a wider step than most.
- All three prices are floors with no rung above them published.
- No milligram appears against any figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Options Medical Weight Loss is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#309 of 373
Ordered with the companies that pay us first, and Options Medical Weight Loss is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.